Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Pfizer board member Gottlieb says the Covid pandemic could be over in the U.S. by January

by
November 5, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Sam Altman didn’t take any equity in OpenAI, report says

‘It was agony’: Why SVB’s collapse is especially hard as a Black founder, says CEO

The Covid-19 pandemic could be over in the U.S. by the time President Biden’s workplace vaccine mandates take effect in early January, Pfizer board member Dr. Scott Gottlieb told CNBC’s “Squawk Box” Friday.

The vaccine requirements from the Occupational Safety and Health Administration begin on Jan. 4 for any company with at least 100 employees. Some 84 million private sector workers must get either their second Moderna or Pfizer shot or one dose from Johnson & Johnson by that date or face regular testing for the virus.

“These mandates that are going to be put in place by Jan. 4 really are coming on the tail end of this pandemic,” said Gottlieb, who’s also a former commissioner of the Food and Drug Administration. “By Jan. 4, this pandemic may well be over, at least as it relates to the United States after we get through this delta wave of infection. And we’ll be in a more endemic phase of this virus.”

All companies complying with OSHA’s new rules must also start enforcing indoor mask mandates for unvaccinated employees starting Dec. 5. Those personnel must also start submitting weekly negative Covid tests after Jan. 4 to remain employed, and anyone who tests positive must quarantine away from work.

The federal mandate contains exemptions for religious and medical reasons. Employees who work outdoors, at home or in settings where others aren’t present are also exempt from the rules.

OSHA’s guidance doesn’t mandate that businesses pay for their employees’ Covid tests or masks, but any company caught dodging the rules will face fines of anywhere between $13,653 to $136,532 for intentional noncompliance.

Gottlieb’s comments came in the wake of data from Pfizer that indicated its Covid antiviral pill, when paired with an HIV medication, slashed the potential for hospitalization or death by 89% in adults at risk for severe complications. Combining the pill with an HIV medication slowed the metabolism, allowing the Covid antiviral to work longer in the body.

CEO Albert Bourla said the company will submit data on the therapeutic to the FDA before Thanksgiving in an interview with “Squawk Box” Friday morning.

Gottlieb said Pfizer’s new drug shouldn’t be considered a substitute for vaccinating more Americans against the virus, adding that he thought periodic Covid vaccinations and changes to the vaccines could be necessary moving forward. But he noted that antivirals could help treat cases in a range of high-risk individuals.

“When you have therapeutics that are this effective, that can be a backstop for people for whom vaccines don’t work, people who have breakthrough infections – there’s pills being studied in that setting,” Gottlieb said. “It really is a backstop against death and disease from this infection.”

Pfizer’s announcement arrives a month after Merck and Ridgeback Biotherapeutics said they created an antiviral that cut Covid hospitalizations and deaths by 50% in patients with up to moderate cases. The United Kingdom cleared Merck’s treatment Thursday.

CNBC’s Berkeley Lovelace, Leslie Josephs and Spencer Kimball contributed to this reporting.

Disclosure: Scott Gottlieb is a CNBC contributor and is a member of the boards of Pfizer, genetic testing start-up Tempus, health-care tech company Aetion and biotech company Illumina. He also serves as co-chair of Norwegian Cruise Line Holdings? and Royal Caribbean’s “Healthy Sail Panel.”

ShareTweetPin

Related Posts

Sam Altman didn’t take any equity in OpenAI, report says

by
March 24, 2023
0

Sam Altman, president of Y Combinator, pauses during the New Work Summit in Half Moon Bay, California, U.S., on Monday,...

‘It was agony’: Why SVB’s collapse is especially hard as a Black founder, says CEO

by
March 24, 2023
0

Isa Watson, founder of voice-only social messaging app Squad, was on a plane when she got the news: Silicon Valley...

Europe’s leaders battle banking crisis as market rout hangs over Brussels summit

by
March 24, 2023
0

In this article .BBKADBCSG.N-CH Follow your favorite stocksCREATE FREE ACCOUNT Germany's Chancellor Olaf Scholz said Deutsche Bank is profitable after...

BofA’s Hartnett sees commercial real estate as the ‘next shoe to drop’

by
March 24, 2023
0

Commercial real estate could be the next danger spot in the wobbly U.S. financial sector, according to Bank of America....

TikTok wants to distance itself from China — but Beijing is getting involved

by
March 24, 2023
0

China and U.S. flags are seen near a TikTok logo in this illustration picture taken July 16, 2020. Florence Lo...

Next Post

'End of the war is in sight' -- Cramer says Dr. Gottlieb's end-of-pandemic call bigger than jobs data

1st Look at Local Housing Markets in October

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net